Anal cancer is uncommon accounting for only 2% of anorectal cancers. T
he recognition of many similarities between cervical and anal cancer h
as stimulated research into the identification of a common aetiologica
l agent. DNA from human papillomaviruses has consistently been found i
n both of these cancers and is thought to be an important factor in th
e development of both of these tumours. Simultaneously, epidemiologica
l data from the west coast of America have indicated that the demograp
hy of anal cancer may be changing. Further studies in the USA and the
UK have identified certain groups at high risk of developing anal canc
er. These high-risk groups include 'never married' men and immunosuppr
essed patients both from iatrogenic immunosuppression in transplant pa
tients and those infected with HIV. The potential increase in anal can
cer cases, due to the ever increasing numbers of patients who have rec
eived transplants and the spiralling number of the population infected
with HIV make it timely to review what is known of the aetiology, pre
sentation and management of this cancer.